Cue Biopharma Inc
(CUE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,674 | -50,733 | -53,010 | -44,161 | -44,785 |
| Depreciation Amortization | 434 | 359 | 632 | 1,253 | 1,141 |
| Accounts receivable | 753 | -1,641 | 3,085 | -1,725 | -663 |
| Other Working Capital | -4,925 | -934 | 356 | -4,388 | 5,435 |
| Other Operating Activity | 8,083 | 12,988 | 7,131 | 10,183 | 6,378 |
| Operating Cash Flow | $-36,329 | $-39,961 | $-41,806 | $-38,837 | $-32,494 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 25,000 | -24,445 | 10,000 | 15,000 |
| PPE Investments | 32 | 2 | -165 | -892 | -595 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -9,949 |
| Investing Cash Flow | $32 | $25,002 | $-24,610 | $9,109 | $4,456 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 10,000 | N/A | N/A |
| Common Stock Issued | 10,831 | 473 | 22,702 | 2,599 | 58,885 |
| Other Financing Activity | -588 | 11,387 | 20,957 | 16,635 | -271 |
| Financing Cash Flow | $10,243 | $11,860 | $53,659 | $19,233 | $58,614 |
| Beginning Cash Position | 48,665 | 51,764 | 64,521 | 75,016 | 44,440 |
| End Cash Position | 22,611 | 48,665 | 51,764 | 64,521 | 75,016 |
| Net Cash Flow | $-26,054 | $-3,099 | $-12,757 | $-10,495 | $30,576 |
| Free Cash Flow | |||||
| Operating Cash Flow | -36,329 | -39,961 | -41,806 | -38,837 | -32,494 |
| Capital Expenditure | -66 | N/A | -171 | -913 | -595 |
| Free Cash Flow | -36,395 | -39,961 | -41,977 | -39,750 | -33,089 |